跳至主要内容
临床试验/EUCTR2004-002850-69-GB
EUCTR2004-002850-69-GB进行中(未招募)不适用

Role of High dose insulin and glucose-potassium-magnesium (HDI-GKM) for Myocardial protection in cardiac surgery - Role of insulin glucose potassium magnesium in cardiac surgery

Swansea NHS Trust0 个研究点目标入组 90 人开始时间: 2005年8月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Males or females with symptomatic coronary artery disease, undergoing first time urgent coronary revascularization, categorised as follows:-
  • Acute Coronary Syndrom: including nonST elevation myocardial infarction (NSETMI), Troponin positive unstable angina and myocardial infarction
  • Post infarct angina
  • Severe two or three vessel coronary artery disease or left main stem stenosis requiring revascularization
  • Severe coronary artery disease with impaired left ventricular function
  • Are the trial subjects under 18?
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1 Liver disease
  • 2 Chronic severe renal disease
  • 3 Patients who require procedures in combination with CABG (valve repair/replacement, aneurysm repair)
  • 4 Refusal to give informed consent

研究者

发起方
Swansea NHS Trust

相似试验